A patient receives a shot in a potential Covid-19 vaccine trial at a health research institute in Seattle in March.
The findings, published in the Lancet medical journal, showed that on average, people who got the triple-drug reached the point of no detectable virus five days earlier than those in the control group – at 7 days versus 12 days. In the trial, all patients received standard hospital care as needed, including ventilation support, dialysis support, antibiotics and corticosteroids.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: